| Gender |
|
|
| Male |
57.6% |
34/59 |
| Female |
42.4% |
25/59 |
| Indifferent |
0% |
0/59 |
| Unknown |
0% |
0/59 |
| General |
|
|
| Birth Length abnormalities |
0% |
0/59 |
| Birth Weight abnormalities |
1.7% |
1/59 |
| < P3 : Small for gestational age |
1.7% |
1/59 |
| Birth Head circumference abnormalities |
1.7% |
1/59 |
| < P3 : Congenital microcephaly |
1.7% |
1/59 |
| Current Height abnormalities |
5.1% |
3/59 |
| < P3 : Short stature |
5.1% |
3/59 |
| Current Weight abnormalities |
5.1% |
3/59 |
| < P3 : Decreased body weight |
5.1% |
3/59 |
| Current Head circumference abnormalities |
33.9% |
20/59 |
| < P3 : Microcephaly |
33.9% |
20/59 |
| Neurology |
|
|
| Neurological abnormalities |
95.7% |
45/47 |
| Muscular hypotonia |
63.8% |
30/47 |
| Gait ataxia |
25.5% |
12/47 |
| EEG abnormality |
21.3% |
10/47 |
| Dysarthria |
19.1% |
9/47 |
| Abnormality of the autonomic nervous system |
10.6% |
5/47 |
| Generalized tonic-clonic seizures |
8.5% |
4/47 |
| Ataxia |
6.4% |
3/47 |
| Focal seizures |
6.4% |
3/47 |
| Seizures |
6.4% |
3/47 |
| Absence seizures |
4.3% |
2/47 |
| Focal myoclonic seizures |
4.3% |
2/47 |
| Generalized myoclonic seizures |
4.3% |
2/47 |
| Speech apraxia |
4.3% |
2/47 |
| Atonic seizures |
2.1% |
1/47 |
| Delayed speech and language development |
2.1% |
1/47 |
| Facial hypotonia |
2.1% |
1/47 |
| Generalized seizures |
2.1% |
1/47 |
| Generalized tonic seizures |
2.1% |
1/47 |
| Infantile muscular hypotonia |
2.1% |
1/47 |
| Myoclonic spasms |
2.1% |
1/47 |
| Toe walking |
2.1% |
1/47 |
| Behavioral problems |
78.2% |
43/55 |
| Behavioral abnormality |
60.0% |
33/55 |
| Autism |
32.7% |
18/55 |
| Repetitive compulsive behavior |
29.1% |
16/55 |
| Sleep disturbance |
29.1% |
16/55 |
| Aggressive behavior |
27.3% |
15/55 |
| Attention deficit hyperactivity disorder |
21.8% |
12/55 |
| Absent speech |
18.2% |
10/55 |
| Anxiety |
10.9% |
6/55 |
| Depression |
1.8% |
1/55 |
| Dysgraphia |
1.8% |
1/55 |
| Dyslexia |
1.8% |
1/55 |
| Brain abnormality |
60.9% |
28/46 |
| Abnormality of the posterior cranial fossa |
32.6% |
15/46 |
| Abnormality of brainstem morphology |
30.4% |
14/46 |
| Abnormality of the corpus callosum |
19.6% |
9/46 |
| Abnormality of brain morphology |
10.9% |
5/46 |
| Abnormality of the cerebellar vermis |
2.2% |
1/46 |
| Abnormality of the cerebral cortex |
2.2% |
1/46 |
| Cortical dysplasia |
2.2% |
1/46 |
| Gliosis |
2.2% |
1/46 |
| Ventriculomegaly |
2.2% |
1/46 |
| Facial abnormalities |
|
|
| Abnormality of the ear |
65.3% |
32/49 |
| Abnormality of the outer ear |
57.1% |
28/49 |
| Attached earlobe |
6.1% |
3/49 |
| Overfolded helix |
4.1% |
2/49 |
| Prominent antihelix |
4.1% |
2/49 |
| Auricular tag |
2.0% |
1/49 |
| Cupped ear |
2.0% |
1/49 |
| Low-set ears |
2.0% |
1/49 |
| Microtia |
2.0% |
1/49 |
| Posteriorly rotated ears |
2.0% |
1/49 |
| Protruding ear |
2.0% |
1/49 |
| Abnormality of the eye |
57.1% |
20/35 |
| Epicanthus |
51.4% |
18/35 |
| Downslanted palpebral fissures |
8.6% |
3/35 |
| Abnormality of eye movement |
2.9% |
1/35 |
| Blue sclerae |
2.9% |
1/35 |
| Ptosis |
2.9% |
1/35 |
| Telecanthus |
2.9% |
1/35 |
| Abnormality of the nose |
60.0% |
27/45 |
| Wide nose |
57.8% |
26/45 |
| Broad nasal tip |
11.1% |
5/45 |
| Abnormality of the nares |
4.4% |
2/45 |
| Anteverted nares |
2.2% |
1/45 |
| Depressed nasal bridge |
2.2% |
1/45 |
| Prominent nasal bridge |
2.2% |
1/45 |
| Abnormality of the mouth |
83.0% |
44/53 |
| Abnormality of lower lip |
52.8% |
28/53 |
| Thin upper lip vermilion |
39.6% |
21/53 |
| Abnormality of the palate |
9.4% |
5/53 |
| Retrognathia |
7.5% |
4/53 |
| High palate |
5.7% |
3/53 |
| Cleft palate |
1.9% |
1/53 |
| Micrognathia |
1.9% |
1/53 |
| Narrow mouth |
1.9% |
1/53 |
| Wide mouth |
1.9% |
1/53 |
| Visual and hearing impairments |
|
|
| Abnormal hearing |
5.3% |
1/19 |
| Hearing impairment |
5.3% |
1/19 |
| Abnormal vision |
72.5% |
29/40 |
| Strabismus |
72.5% |
29/40 |
| Amblyopia |
2.5% |
1/40 |
| Hypermetropia |
2.5% |
1/40 |
| Gastrointestinal |
|
|
| Gastrointestinal abnormalities |
40.0% |
14/35 |
| Constipation |
37.1% |
13/35 |
| Gastroesophageal reflux |
2.9% |
1/35 |
| Urogenital |
|
|
| Abnormality of the urogenital system |
32.0% |
8/25 |
| Cryptorchidism |
12.0% |
3/25 |
| Hydronephrosis |
4.0% |
1/25 |
| Hydrocele testis |
4.0% |
1/25 |
| Micropenis |
4.0% |
1/25 |
| Phimosis |
4.0% |
1/25 |
| Urethral stenosis |
4.0% |
1/25 |
| Vesicoureteral reflux |
4.0% |
1/25 |
| Skeleton |
|
|
| Skeletal abnormalities |
60.0% |
27/45 |
| Joint hypermobility |
42.2% |
19/45 |
| Scoliosis |
17.8% |
8/45 |
| Abnormality of finger |
2.2% |
1/45 |
| Abnormality of the metacarpal bones |
2.2% |
1/45 |
| Clinodactyly of the 2nd toe |
2.2% |
1/45 |
| Congenital hip dislocation |
2.2% |
1/45 |
| Coxa valga |
2.2% |
1/45 |
| Kyphosis |
2.2% |
1/45 |
| Marked delay in bone age |
2.2% |
1/45 |
| Pectus excavatum |
2.2% |
1/45 |
| Postaxial foot polydactyly |
2.2% |
1/45 |
| Postaxial hand polydactyly |
2.2% |
1/45 |
| Valgus foot deformity |
2.2% |
1/45 |
| Skin / Hair / Nails |
|
|
| Abnormality of the skin/hair/nails |
55.2% |
16/29 |
| Hypertrichosis |
37.9% |
11/29 |
| Fine hair |
6.9% |
2/29 |
| Atopic dermatitis |
3.4% |
1/29 |
| Frontal upsweep of hair |
3.4% |
1/29 |
| High anterior hairline |
3.4% |
1/29 |
| High posterior hairline |
3.4% |
1/29 |
| Medial flaring of the eyebrow |
3.4% |
1/29 |
| Prominent digit pad |
3.4% |
1/29 |
| Sparse eyebrow |
3.4% |
1/29 |
| Supernumerary nipple |
3.4% |
1/29 |
| Endocrine / Immunological / Metabolic |
|
|
| Abnormality of the endocrine system |
50.0% |
1/2 |
| Hypothyroidism |
50.0% |
1/2 |
| Abnormality of the immune system |
9.5% |
2/21 |
| Bronchiectasis |
4.8% |
1/21 |
| Panhypogammaglobulinemia |
4.8% |
1/21 |
| Recurrent otitis media |
4.8% |
1/21 |
| Recurrent pneumonia |
4.8% |
1/21 |
| Neoplasia |
|
|
| Neoplasia |
1.7% |
1/59 |
| Osteochondroma |
1.7% |
1/59 |